Показать сообщение отдельно
  #35  
Старый 13.02.2010, 00:14
Аватар для Sereda Andrey
Sereda Andrey Sereda Andrey вне форума
травматолог-ортопед
      
 
Регистрация: 04.04.2006
Город: Москва
Сообщений: 5,314
Поблагодарили 1,238 раз(а) за 1,136 сообщений
Sereda Andrey этот участник имеет превосходную репутацию на форумеSereda Andrey этот участник имеет превосходную репутацию на форумеSereda Andrey этот участник имеет превосходную репутацию на форумеSereda Andrey этот участник имеет превосходную репутацию на форумеSereda Andrey этот участник имеет превосходную репутацию на форумеSereda Andrey этот участник имеет превосходную репутацию на форумеSereda Andrey этот участник имеет превосходную репутацию на форумеSereda Andrey этот участник имеет превосходную репутацию на форумеSereda Andrey этот участник имеет превосходную репутацию на форумеSereda Andrey этот участник имеет превосходную репутацию на форумеSereda Andrey этот участник имеет превосходную репутацию на форуме
91. Samama CM, Vray M, Barr J, Fiessinger JN, Rosencher N. Lecompte T. Potrуn G. Basile J. Hull R. Desmichels D; SACRE Study Investigators. Extended venous thromboembolism prophylaxis after total hip replacement: a comparison of low-molecular-weight heparin with oral anticoagulant. Arch Intern Med. 2002:162:2191-6.
92. Schijnemann HJ, Munger H, Brower S, O'Donnell M. Crowther M. Cook D. Guyatt G. Methodology for guideline development for the Seventh American College of Chest Physicians Conference on Antithrombotic and Thrombolytic Therapy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004:126(3 Suppl):174S-178S.
93. Sculco TP. Colwell CW Jr. Pellegrini VD Jr. Westrich GH, Bottner F. Prophylaxis against venous thromboembolic disease in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am. 2002;84;466-77.
94. Seshadri T. Tran H. Lau KK. Tan B. Gan TE. Ins and outs of inferior vena cava filters in patients with venous thromboembolism: the experience at Monash Medical Centre and review of the published reports. Intern Med J. 2008:38:38-43.
95. Sharrock NE. Go G. Harpel PC. Ranawat CS. Sculco TP, Salvati EA. Thrombogenesis during total hip arthroplasty. Clin Orthop Relat Res. 1995;319:16-27.
96. Sharrock NE. Hargett MJ. Urquhart B. Peterson MG, Ranawat C, Insall J, Windsor R. Factors affecting deep vein thrombosis rate following total knee arthroplasty under epidural anesthesia. J Arthroplasty. 1993:8:133-9.
97. Silbersack Y. Taute BM. Hein VV. Podhaisky H. Prevention of deep-vein thrombosis after total hip and knee replacement. Low-molecular-weight heparin in combination with intermittent pneumatic compression. J Bone Joint Surg Br. 2004:86:809-12.
98. SooHoo NF. Lieberman JR. Ko CY. Zingmond DS. Factors predicting complication rates following total knee replacement. J Bone Joint Surg Am. 2006;88;480-5.
99. Specifications manual for National Hospital Quality Measures, [Ссылки доступны только зарегистрированным пользователям ]. Accessed 2007 Apr 15.
100. Turpie AG. Bauer KA. Eriksson Bl. Lassen MR; PENTATHALON 2000 Study Steering Committee. Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial. Lancet. 2002:359:1721-6. Erratum in: Lancet. 2002:360:1102.
101. Vresilovic EJ Jr. Hozack WJ. Booth RE. Rothman RH. Incidence of pulmonary embolism after
total knee arthroplasty with low-dose Coumadin prophylaxis. Clin Orthop Relat Res. 1993;286;27-31.
102. Warwick D. Harrison J. Glew D, Mitchelmore A, Peters TJ, Donovan J. Comparison of the use of a foot pump with the use of low-molecular-weight heparin for the prevention of deep-vein thrombosis after total hip replacement. A prospective, randomized trial. J Bone Joint Surg Am. 1998:80:1158-66.
103. Wenzl ME. Hasse W. Seide K. Wolter O. Prevention of thromboembolism with low-molecular-weight heparin in orthopedic surgery: a 5-year experience. Clin Appl Thromb Hemost. 2004;10:1-4.
104. Westrich GH. Bottner F. Windsor RE. Laskin RS. Haas SB, Sculco TP. Vena Flew plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty. J Arthroplasty. 2006:21(6 Suppl 2):139-43.
105. Westrich GH. Farrell C. Bono JV. Ranawat CS. Salvati EA, Sculco TP. The incidence of venous thromboembolism after total hip arthroplasty: a specific hypotensive epidural anesthesia protocol. J Arthroplasty. 1999:14:456-63.
106. Westrich GH. Haas SB. Mosca P. Peterson M. Meta-analysis of thromboembolic prophylaxis after total knee arthroplasty. J Bone Joint Surg Br. 2000;82;795-800.
107. Westrich GH. Jhon PH. Sanchez PM. Compliance in using a pneumatic compression device after total knee arthroplasty. Am J Orthop. 2003:32:135-40.
108. Westrich GH. Rana AJ. Terry MA. Taveras NA. Kapoor K, Helfet DL. Thromboembolic disease prophylaxis in patients with hip fracture: a multimodal approach. J Orthop Trauma. 2005;19:234-40.
109. Westrich GH. Sculco TP. Prophylaxis against deep venous thrombosis after total knee arthroplasty. Pneumatic plantar compression and aspirin compared with aspirin alone. J Bone Joint Surg Am. 1996:78:826-34.
110. Westrich GH. Specht LM. Sharrock NE. Sculco TP. Salvati EA. Pellicci PM. Trombley JF. Peterson M. Pneumatic compression hemodynamics in total hip arthroplasty. Clin Orthop Relat Res. 2000:372: 180-91.
111. Westrich GH. Specht LM. Sharrock NE. Windsor RE. Sculco TP. Haas SB. Trombley JF. Peterson M. Venous haemodynamics after total knee arthroplasty: evaluation of active dorsal to plantar flexion and several mechanical compression devices. J Bone Joint Surg Br. 1998:80:1057-66.